Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05668767
What this trial is testing

Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Beijing Chest Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00868192
What this trial is testing

Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma

Who this might be right for
Ovarian CarcinomaPrimary Peritoneal Carcinoma
Washington University School of Medicine 38
Testing effectiveness (Phase 2)WithdrawnNCT02662634
What this trial is testing

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
GU Research Network, LLC
Testing effectiveness (Phase 2)Looking for participantsNCT07014150
What this trial is testing

Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Resectable
Peking Union Medical College Hospital 33
Not applicableStudy completedNCT06111560
What this trial is testing

Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Sun Yat-sen University 160
Testing effectiveness (Phase 2)Ended earlyNCT01403259
What this trial is testing

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 16
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Study completedNCT00462488
What this trial is testing

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

Who this might be right for
Urinary Bladder CancerBladder CancerBladder Neoplasms+1 more
Sesen Bio, Inc. 46
Testing effectiveness (Phase 2)Looking for participantsNCT07339488
What this trial is testing

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Borderline Resectable CarcinomaUnresectable CancerEsophageal Squamous Cell Carcinoma (ESCC)+4 more
Chuangzhen Chen 43
Large-scale testing (Phase 3)Looking for participantsNCT06598527
What this trial is testing

Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study

Who this might be right for
Lung Cancer (NSCLC)
Yang Hong 360
Not applicableStudy completedNCT04635761
What this trial is testing

Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening

Who this might be right for
Lung Carcinoma
Roswell Park Cancer Institute 292
Testing effectiveness (Phase 2)Looking for participantsNCT06516289
What this trial is testing

Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab

Who this might be right for
BRCA-Mutated Breast CarcinomaHER2-negative Breast Cancer
Fudan University 130
Testing effectiveness (Phase 2)UnknownNCT04984018
What this trial is testing

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 73
Large-scale testing (Phase 3)Active Not RecruitingNCT01993810
What this trial is testing

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Who this might be right for
Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7+3 more
Radiation Therapy Oncology Group 330
Not applicableLooking for participantsNCT05834413
What this trial is testing

Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Who this might be right for
Lung Cancer
Shanghai University of Traditional Chinese Medicine 367
Testing effectiveness (Phase 2)WithdrawnNCT06522360
What this trial is testing

Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)

Who this might be right for
Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04421820
What this trial is testing

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Who this might be right for
Colorectal CancerPancreatic CancerGastric Cancers+1 more
Bold Therapeutics, Inc. 220
Not applicableEnded earlyNCT03607682
What this trial is testing

Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Carcinoma
Vanderbilt-Ingram Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT04293679
What this trial is testing

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC

Who this might be right for
Bowen's DiseaseCutaneous Squamous Cell Carcinoma in Situ
Sirnaomics 25
Not applicableUnknownNCT03975127
What this trial is testing

Cervical Cytology - Do SMS Reminders Increase Participation in the Cervical Screening Programme?

Who this might be right for
Cervical CarcinomaCervical Dysplasia
NHS Greater Glasgow and Clyde 50,000
Next Page